Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Dec 23, 2023 3:34pm
430 Views
Post# 35799293

Another week, month & year….

Another week, month & year….

First, it was questioned why I don't post on the other sites.
Part to do with a technical issue, part to do with the on- going censorship of my posts.
Once again, the efforts of a few destroyed the integrity & continuum of the site. To a bunch of useless babble, bashing & intentionally suppressing anything in a positive light what so ever.
Last & most importantly I'm dealing with some extremely complicated life/ death family situations.
Nothing to do with Onc at all. Does however use up a lot of my time & energy.
Moving on......
onc?

The trading for this month & year is almost over.
I don't expect anything major. That being with the SP , or announcements, until early January.
I did post previously to expect a surprise first of the year.
Why " surprise "?
The lead up to last few days has been remarkable, yet not discussed formally.
Andrew D, is gone, yet investor presentation still not updated since early November.
They are looking to higher a technical writer.
They have 2 phase 3 ready opportunities, yet no announced pathway.
On the $$ side, they must have a partner or buyout to get to phase 3. 
or if going alone a very complex equity issue. Certainly giving more than 10% of the company to  the financier.
Lots of unknowns. At this stage nothing would surprise me. 
Questions need to be answered. 

No doubt lots of discussions Internally & at the BOD level.
FYI it was stated many years ago, a takeover would be best suited as early in the year as possible.
Both for financial & logistics reasons.
They won't be going out of business, , won't be doing a reverse split, no need actually.
Saying that. They need a profound change. Loosing Andrew D, is part of that direction.
I have been in various stocks since 1978. Seen many things happen.
I do have a bundle of theories. None I will post, as pre mentioned my words get quoted & taken out of context.
Just know this, by mid Jan things will not be the same old same old @ Onc.
We can only hope the business side starts to line up with the science.
right now, there is a Grand Canyon size gap in the trading price & where it should be.
Wishing everyone a safe & happy seasonal holiday.
 

 


 

<< Previous
Bullboard Posts
Next >>